[Costs for treatment of very-low-birth-weight infants]

Anja Nordermoen1, Dag Bratlid

  • 1Det medisinske fakultet, Medisinsk-teknisk forskningssenter, Norges teknisk-naturvitenskapelige universitet, Trondheim, Norway.

Insights

The cost of treating very-low-birth-weight infants increased overall, but the cost per healthy surviving infant decreased between 1997 and 2007 due to improved medical care. These infants represent a significant hospital cost.

Area of Science:

  • Neonatal care
  • Health economics
  • Pediatric intensive care

Context:

  • Rising costs of advanced medical technology and labor impact premature infant treatment.
  • Limited Norwegian research exists on the economic aspects of neonatal intensive care.
  • St. Olavs University Hospital's treatment costs for very-low-birth-weight infants were assessed.

Purpose:

  • To evaluate the treatment costs for very-low-birth-weight infants in a Norwegian hospital.
  • To compare these costs between infants born in 1997 and 2007.
  • To analyze the economic implications of improved survival rates.

Summary:

  • Mean treatment costs per patient increased from 475,131 NOK in 1997 to 603,238 NOK in 2007.
  • Despite overall cost increases, the cost for a healthy surviving infant decreased from 1,135,035 NOK in 1997 to 922,599 NOK in 2007.
  • Diagnostic Related Group (DRG) reimbursements adequately cover costs for infants weighing 1000-1499g but not those below 1000g.

Impact:

  • Very-low-birth-weight infants are likely the most expensive patient group, with a mean cost of 900,000 NOK in 2007.
  • Improved survival rates without serious complications reduce the long-term cost per healthy infant.
  • Current reimbursement structures may not fully cover the treatment costs for the most vulnerable premature infants.
Abstract